AZ-13581258

N/A

Report date: 2022/04/12 11:14:22

NME

Base Information

Drug NameAZ-13581258

Drug Alias NameAZ-13581258

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Action5-lipoxygenase activating protein inhibitors

Targets5-lipoxygenase activating protein

Therapy Area/IndicationsLung Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesAstrazeneca Plc

Inactive CompaniesN/A

Active IndicationsLung Diseases

Inactive IndicationsN/A

ATC CodeN/A